Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Division Of Personalized Genomic Medicine, |
RCV003330090 | SCV004037350 | uncertain significance | Focal segmental glomerulosclerosis 2 | 2019-11-04 | criteria provided, single submitter | clinical testing | The c.266G>T variant is a missense variant that substitutes a serine residue to an isoleucine at amino acid position 89 (p.Ser89Ile). This variant localizes to coding exon 2 of the TRPC6 gene (13 coding exons in total; NM_004621.5). Most reported pathogenic variants in TRPC6 are missense. However, to the best of our knowledge, this variant has not been reported in the literature previously. It was also absent in the genome aggregation database (gnomAD), indicating it is not a common benign variant in the population represented in the database. In silico predictors show mixed results for this variant. |
Gharavi Laboratory, |
RCV000681839 | SCV000809316 | likely pathogenic | not provided | 2018-09-16 | no assertion criteria provided | research |